 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE--Kezar Life Sciences, Inc. Nasdaq: KZR, a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that Christopher Kirk, PhD, Co-founder, President and Chief Scientific Officer, will participate in three upcoming investor conferences in September. Presentation Details: Event: 2022 Wells Fargo Healthcare Conference Location: Boston, MA DateTime: Thursday, S 